Nuclear Medicine
CLINICAL DECISION SUPPORT
| Clinical Evaluation |
|---|
| Glucose metabolism |
| Type of Imaging |
| PET |
| Grade of Recommendation |
| B (generally recommended) |
| Level of Evidence |
| well-established clinical and NM recommendations recommendations |
| Effective Dose |
| 19.0 µSv/MBq |
| Bibliographic Reference |
|
Hess, S. FDG-PET/CT in Fever of Unknown Origin, Bacteremia, and Febrile Neutropenia. PET Clin. 2020; https://doi.org/10.1016/j.cpet.2019.11.002. <... read more Hess, S. FDG-PET/CT in Fever of Unknown Origin, Bacteremia, and Febrile Neutropenia. PET Clin. 2020; https://doi.org/10.1016/j.cpet.2019.11.002. Hess, S. ([18F]FDG-PET/CT in patients with bacteremia: Clinical impact on patient management and outcome. Front Med (Lausanne); https://doi.org/10.3389/fmed.2023.1157692. Thottacherry, E., & Cortés-Penfield, N. W. Evidence of Clinical Impact Supports a New Petition for Medicare Coverage of 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in the Evaluation of Staphylococcus aureus Bacteremia: A Focused Literature Review and Call to Action. Clin Infect Dis. 2022; https://doi.org/10.1093/cid/ciac363. read less |
| Guide to Nuclear Medicine |
| Read the corresponding chapter |